Capecitabine
- Product NDC
- 51079-510
- 11-digit product format
- 510790510
- Labeler code
- 51079
- Product ID
- 51079-510_d44fb784-154f-00b2-e053-2995a90ace6a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- capecitabine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Mylan Institutional Inc.
- Application
- ANDA090943
- Marketing category
- ANDA
- Marketing start
- 2014-01-21
- Marketing end
- 2022-05-31
- Substance
- CAPECITABINE
- Active strength
- 500 mg/1
- Pharmacologic classes
- Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51079-510-05 | 51079051005 | 20 BLISTER PACK in 1 CARTON (51079-510-05) > 1 TABLET, FILM COATED in 1 BLISTER PACK (51079-510-01) | 20 blister pack | 2014-01-21 | 0000-00-00 | No | No | Current |